Medical Licensing (MD/DO) · Independent exam preparation
ABTS Primary Certification Part I (Written): Decision-Based Preparation Study Guide
Practise operative selection, cardiopulmonary physiology, cancer assessment and postoperative rescue across the ABTS written examination's nine clinical domains.
By CertMedbry · Updated 19 October 2026
Practise choosing an operation, interpreting physiologic risk, investigating suspicious findings and rescuing postoperative complications. This guide targets the American Board of Thoracic Surgery Primary Certification Part I (Written) Examination within the United States specialty board certification process. Its 60 concepts selectively sample all nine domains; the official ABTS written matrix defines the full scope, including topics beyond this guide.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and certification pathway does this guide cover?
This guide covers the Primary Certification Part I (Written) Examination in the ABTS initial-certification pathway. The issuer also calls its content outline the Qualifying (Written) Exam Matrix. These names refer to the written component; passing Part I alone does not complete certification. The initial-certification examination cycle includes both Part I (Written) and Part II (Oral).
ABTS Examination Sequence · ABTS Primary Certification Part I (Written) Examination · ABTS Qualifying (Written) Exam Matrix
How many questions are published, and is the scored/pretest split established?
The ABTS Part I detail page publishes a total of 250 multiple-choice questions. It does not establish how many are scored or pretest items. Treat the published total as subject to current candidate instructions, particularly because the detail page retains older scheduling language. The 20 questions in this learning set are independent practice drills.
ABTS Primary Certification Part I (Written) Examination · ABTS Training and Initial Certification
What duration and delivery setting does ABTS publish?
The Part I detail page describes electronic delivery at Pearson Professional Testing Centers and two equal sections of 2 hours 45 minutes, totaling 5.5 hours of testing. That total does not establish break allowances or total appointment length. Its older single-day annual scheduling language differs from the current December 7–11, 2026 examination window; the window is not an individual examination's duration. Current candidate instructions govern appointments, breaks and available centers. Adaptive delivery and remote testing availability are not established by these pages.
ABTS Training and Initial Certification · ABTS Primary Certification Part I (Written) Examination
Which item styles are verified, and how should these drills be used?
ABTS describes multiple-choice questions using brief statements or case histories, sometimes accompanied by graphics or pictures, followed by a question and possible answers. The page does not establish a fixed answer-option count or adaptive delivery. This set uses four-option, single-best-answer questions for learning and does not reproduce the official interface or predict passing.
Which blueprint applies, and what do its percentages mean?
The current linked Qualifying (Written) Exam Matrix was verified on October 18, 2026. It gives approximately 50% Cardiac and 50% General Thoracic. Component ranges are Acquired Heart Disease 25–35%, Congenital Heart Disease 5–10%, General Management 10–20%, Lung 20–30%, Trachea/Bronchi 3–10%, Pleura 5–10%, Mediastinum 5–10%, Esophagus 5–10%, and Chest Wall/Diaphragm 1–8%. These are overall-examination ranges, not fixed quotas. The detail page describes ranges as reflecting prior years. No matrix publication date, version number or effective date is stated.
ABTS Qualifying (Written) Exam Matrix · ABTS Primary Certification Part I (Written) Examination
How does this selective guide distribute its content?
The guide assigns 18 concepts to acquired cardiac disease, four to congenital cardiac disease, eight to cardiac management, 12 to lung, four each to airway and pleura, three to mediastinum, four to esophagus and three to chest wall/diaphragm. Questions and flashcards each allocate ten items to Cardiac and ten to General Thoracic, with every domain represented. These educational allocations fit the published ranges but cannot cover every matrix topic.
Which TNM edition should candidates prepare?
The current ABTS initial-certification page specifies ninth-edition AJCC TNM staging for both examination parts. The linked Part I detail page retains a conflicting eighth-edition notice. Use the current ninth-edition notice as the preparation reference and resolve any examination-specific discrepancy through current ABTS candidate guidance. This set avoids edition-sensitive stage-group questions.
ABTS Training and Initial Certification · ABTS Primary Certification Part I (Written) Examination
What examination dates and eligibility milestones are verified?
The current page lists December 7–11, 2026, for the written examination. The examination-sequence page requires successful completion of both parts and describes application approval as the basis for Board-Eligible status. It also describes time limits and attempt rules. Individual eligibility and scheduling depend on current ABTS requirements and approval; the listed window does not itself establish an appointment.
ABTS Training and Initial Certification · ABTS Examination Sequence
Part I assesses cognitive knowledge for initial thoracic surgery certification. Initial certification also requires Part II (Oral). Continuing certification and congenital cardiac surgery subspecialty certification are separate examinations. These independently authored questions and flashcards are educational materials without ABTS endorsement.
Outline used: Current ABTS Qualifying (Written) Exam Matrix, accessed 2026-10-10; no publication date, version number, or effective date is stated. The workbook label 'American Board of Thoracic Surgery Certification' describes the broader initial-certification process, which includes Part I (Written) and Part II (Oral). This learning set maps that label to the officially named Primary Certification Part I (Written) Examination while preserving the assigned slug. The current initial-certification page specifies ninth-edition TNM staging; the linked Part I detail page retains a conflicting eighth-edition notice.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Cardiac — Acquired Heart Disease25–35%
1.When does diabetes favor CABG over PCI?
For a suitable surgical candidate with diabetes and multivessel coronary disease involving the LAD, CABG is generally preferred to PCI to reduce mortality and repeat revascularization. The decision depends on coronary anatomy, achievable completeness of revascularization, operative risk and patient preferences. Diabetes alone does not mandate surgery for every coronary lesion. The discriminating pattern is diabetes plus substantial multivessel disease, particularly when durable grafting of the LAD and other important territories is feasible.
Apply it
A patient with diabetes has severe LAD, circumflex and right coronary disease, preserved functional independence and acceptable operative risk. Compare durable multivessel CABG with PCI rather than treating each stenosis as an isolated catheter-based problem.
Common pitfall: Choosing PCI solely because it is less invasive overlooks the prognostic importance of diabetes and multivessel anatomy in an otherwise suitable surgical candidate.
ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
2.How does significant left-main disease influence revascularization?
Significant left-main coronary disease threatens a large myocardial territory and is an important setting in which revascularization can improve survival. CABG remains a central treatment, particularly when associated coronary disease is complex. PCI can be reasonable in selected patients whose anatomy is suitable and in whom comparable revascularization is achievable. A Heart Team should integrate anatomical complexity, surgical risk and the patient's goals rather than applying a universal procedure choice to every left-main lesion.
Apply it
Angiography shows distal left-main bifurcation disease with diffuse three-vessel involvement in a patient with acceptable operative risk. The extensive anatomy strengthens the case for CABG and a multidisciplinary revascularization discussion.
Common pitfall: Treating all left-main lesions as equivalent ignores the difference between a focal, technically suitable lesion and complex bifurcation disease with diffuse downstream involvement.
ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
3.Why is an internal mammary artery used for the LAD?
An internal mammary artery graft to the LAD is a foundational CABG strategy because durable arterial patency supports long-term myocardial perfusion. The LAD usually supplies a substantial portion of the left ventricle, making conduit durability especially consequential. Conduit selection still requires assessment of usable vessel quality and target anatomy. The principle is to match the most durable available conduit to an important coronary territory, rather than choosing every graft simply for speed or ease of harvest.
Apply it
During planning for three-vessel CABG, the LAD is graftable and the left internal mammary artery is suitable. Assign that arterial conduit to the LAD before selecting conduits for the remaining coronary targets.
Common pitfall: Using vein grafts for every target because they are convenient sacrifices the established role of internal mammary arterial grafting when suitable anatomy permits it.
ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
4.Which target characteristics favor a radial artery graft?
The radial artery is preferred over a saphenous vein for an appropriate, significantly stenosed non-LAD target in many CABG patients. Severe native stenosis limits competitive flow, which can undermine an arterial graft when the native vessel still carries substantial blood. Selection also requires a suitable radial artery and adequate hand collateral circulation. Previous radial instrumentation and the possibility of future dialysis access can affect suitability; the recommendation is not an instruction to harvest every available radial artery.
Apply it
A second coronary target has critical stenosis and good distal runoff. The patient has a usable radial artery, adequate collateral hand perfusion and no anticipated dialysis-access requirement, supporting consideration of a radial conduit.
Common pitfall: Grafting a moderately narrowed vessel with a radial artery can create competitive flow; target severity matters alongside the general preference for arterial conduits.
ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
5.How should a young patient with severe aortic stenosis be evaluated?
When aortic valve replacement is indicated, the [2020 ACC/AHA guideline](https://www.jacc.org/doi/10.1016/j.jacc.2020.11.018) recommends surgical aortic valve replacement for patients younger than 65 years or with life expectancy greater than 20 years, subject to individual surgical candidacy and shared decision-making. This provides an actionable starting preference for a young, low-risk patient. Lifetime planning also considers prosthesis durability, anticoagulation, future coronary access, feasibility of subsequent interventions and associated coronary or ascending-aortic disease. Choosing surgery and choosing a mechanical versus biological prosthesis are related but separate decisions.
Apply it
For a physically active 54-year-old with symptomatic severe aortic stenosis and acceptable surgical risk, begin with a recommendation for surgical valve replacement. Assess bicuspid anatomy and aortopathy, then discuss mechanical-valve durability and lifelong vitamin K antagonist therapy versus biological-valve degeneration and possible future intervention. Incorporate the patient's preferences into the final plan.
Common pitfall: Shorter recovery after transcatheter replacement does not outweigh every lifetime consideration. Conversely, age alone does not establish surgical candidacy: major comorbidity, anatomy and the patient's informed preferences can change the individualized recommendation.
ACC Decision-Making Approach to Treat Young and Low-Risk AS Patients · ESC Overview of the 2025 ESC/EACTS Valvular Heart Disease Guidelines
6.Why can bicuspid anatomy favor surgical valve replacement?
Bicuspid aortic valves can have asymmetric calcification, an abnormal raphe and associated ascending aortic disease. These features affect transcatheter expansion, sealing and procedural planning. Surgery also permits treatment of concomitant aortopathy when indicated. In younger patients, bicuspid anatomy strengthens the importance of surgical assessment and lifetime planning. It is an anatomical decision, not a rule that every bicuspid valve requires immediate surgery or that transcatheter treatment is impossible in every selected patient.
Apply it
A young patient with severe bicuspid stenosis also has an ascending aneurysm meeting an operative indication. A surgical strategy can address both the obstructed valve and diseased aorta during one planned intervention.
Common pitfall: Applying outcomes from typical tricuspid-valve populations without examining bicuspid anatomy and the ascending aorta can miss a major reason to select surgery.
ACC Decision-Making Approach to Treat Young and Low-Risk AS Patients · ESC Overview of the 2025 ESC/EACTS Valvular Heart Disease Guidelines
7.What makes valve replacement a lifetime treatment decision?
A first valve procedure changes the feasibility and risk of later procedures. Important considerations include prosthetic durability, residual gradients, patient–prosthesis mismatch, coronary access and whether a later valve-in-valve intervention will be anatomically practical. A small initial prosthesis can constrain future options. Mechanical valves introduce lifelong vitamin K antagonist requirements, whereas tissue valves have structural deterioration concerns. A useful treatment plan therefore anticipates likely future interventions rather than judging success only by uncomplicated hospital discharge.
Apply it
A younger patient with a small aortic annulus prefers a tissue valve. Discuss the predicted prosthesis size, future valve-in-valve limitations and whether the initial surgical plan should improve the platform for later treatment.
Common pitfall: Promising that every tissue valve can later receive a straightforward transcatheter valve ignores coronary obstruction risk, small-valve gradients and other anatomical constraints.
ACC Decision-Making Approach to Treat Young and Low-Risk AS Patients · ESC Overview of the 2025 ESC/EACTS Valvular Heart Disease Guidelines
8.Which anticoagulant is required for a mechanical valve?
Mechanical prosthetic valves require vitamin K antagonist anticoagulation because their surfaces and flow characteristics promote thrombosis. Direct oral anticoagulants are contraindicated for mechanical valves. The target INR depends on valve position, prosthesis characteristics and thromboembolic risk factors; it is not identical for every mechanical prosthesis. The 2020 ACC/AHA guidance generally specifies a target INR of 3.0 for mechanical mitral replacement and 2.5 for a current-generation mechanical aortic valve without additional risk factors.
Apply it
A patient with a mechanical mitral valve asks to replace warfarin with apixaban to avoid INR testing. Explain why the mechanical prosthesis requires a vitamin K antagonist and review the appropriate valve-specific INR target.
Common pitfall: Transferring direct oral anticoagulant recommendations for ordinary nonvalvular atrial fibrillation to a mechanical-valve patient disregards the prosthesis-specific risk and contraindication.
ACC 2020 Heart Valve Disease Guideline: Key Perspectives, Part 3
9.How is suspected prosthetic valve dysfunction investigated?
New dyspnea, embolic events, altered valve sounds or a rising transprosthetic gradient should prompt evaluation for prosthetic dysfunction. Transthoracic echocardiography assesses hemodynamics, but acoustic shadowing may limit structural assessment. Transesophageal echocardiography, fluoroscopy or cardiac CT can clarify leaflet motion, thrombus, pannus or paravalvular pathology when indicated. The discriminating principle is to combine physiology with structural imaging rather than assuming that a technically limited transthoracic examination excludes a clinically important mechanical problem.
Apply it
A mechanical-valve patient develops new exertional dyspnea and a substantially higher gradient than on baseline imaging. Obtain further valve-focused imaging when transthoracic images do not adequately demonstrate leaflet motion or the cause of obstruction.
Common pitfall: Calling the symptoms nonspecific after a limited transthoracic study can delay recognition of prosthetic obstruction, dehiscence or another lesion requiring targeted treatment.
ACC 2020 Heart Valve Disease Guideline: Key Perspectives, Part 3
10.When does interruption of mechanical-valve anticoagulation require bridging?
Bridging decisions depend on prosthesis-related thromboembolic risk and procedural bleeding risk. Under the cited 2020 ACC/AHA approach, a bileaflet mechanical aortic valve without additional thromboembolic risk factors does not routinely require bridging. Mechanical mitral valves, older-generation aortic prostheses and mechanical aortic valves with risk factors warrant consideration of bridging through individualized assessment. Valve position and design therefore matter; neither bridging everyone nor withholding bridging from every mechanical-valve patient captures the risk differences.
Apply it
Two patients need warfarin interruption: one has an uncomplicated bileaflet aortic prosthesis, and the other a mechanical mitral prosthesis. Do not assume their thromboembolic risks or perioperative anticoagulation plans are interchangeable.
Common pitfall: Using a single bridging policy for all mechanical valves ignores valve position, prosthesis generation, additional thromboembolic risks and the bleeding consequences of the planned procedure.
ACC 2020 Heart Valve Disease Guideline: Key Perspectives, Part 3
11.Why does acute type A dissection require urgent surgery?
An acute dissection involving the ascending aorta carries immediate risks of rupture, tamponade, coronary compromise, severe aortic regurgitation and organ malperfusion. Urgent surgical evaluation and repair are indicated. Anti-impulse therapy reduces aortic wall stress while definitive care is organized, but it does not replace surgery for the ascending lesion. The key anatomical discriminator is ascending aortic involvement, even when pain improves or the patient initially appears hemodynamically stable after medical treatment.
Apply it
CT shows an intimal flap in the ascending aorta in a patient whose chest pain improves after blood-pressure control. Continue stabilization while arranging urgent operative management rather than interpreting pain relief as resolution.
Common pitfall: Treating an initially stable type A dissection with observation alone confuses temporary hemodynamic improvement with removal of its ongoing risk of catastrophic ascending aortic complications.
12.Which findings make a type B dissection complicated?
An uncomplicated acute type B dissection is initially managed medically with close monitoring. Rupture, organ malperfusion, extension, progressive enlargement, intractable pain or uncontrolled hypertension indicate complications that can require intervention. Endovascular repair is favored in suitable anatomy for many complicated descending dissections. The distinction is not simply whether the ascending aorta is spared: a descending dissection producing ischemia or uncontrolled progression is no longer a routine medical-observation problem.
Apply it
A patient with descending dissection develops abdominal pain, rising lactate and imaging evidence of mesenteric malperfusion despite anti-impulse therapy. Recognize a complicated dissection and obtain urgent intervention planning rather than continuing medication alone.
Common pitfall: Assuming every type B dissection is managed medically overlooks rupture and malperfusion, which change the treatment category even without ascending aortic involvement.
13.When is a sporadic ascending aortic aneurysm considered for surgery?
For a sporadic aortic root or ascending aneurysm, symptoms attributable to the aneurysm, a diameter of at least 5.5 cm or rapid growth are major surgical indications in the 2022 ACC/AHA guidance. At experienced centers, intervention at 5.0 cm can be reasonable in selected patients. Body size, concurrent valve surgery and heritable conditions can alter decisions. The familiar diameter threshold must therefore be interpreted in the patient's disease category rather than applied indiscriminately to every aortopathy.
Apply it
An otherwise suitable patient has a sporadic ascending aneurysm measuring 5.6 cm on reliable imaging. The diameter meets a standard operative threshold even if the patient has no chest pain or dissection symptoms.
Common pitfall: Applying the sporadic-aneurysm threshold to every patient can delay treatment in higher-risk genetic disease or overlook individualized decisions during another indicated cardiac operation.
14.What constitutes rapid ascending aortic aneurysm growth?
For sporadic aortic root or ascending aneurysms, rapid growth is at least 0.5 cm in one year or at least 0.3 cm per year across two consecutive years. For heritable thoracic aortic disease or bicuspid aortic valve, growth of at least 0.3 cm in one year is considered rapid. Measurements should be compared using consistent techniques and anatomical landmarks. An apparent change caused by different imaging methods should not automatically be treated as confirmed biological enlargement.
Apply it
A sporadic ascending aneurysm measures 4.4, 4.7 and 5.0 cm on comparable annual gated studies. The sustained 0.3-cm annual increase across two years satisfies the rapid-growth definition despite remaining below 5.5 cm.
Common pitfall: Requiring a 0.5-cm increase in every case misses sustained slower growth and the lower one-year growth threshold used for bicuspid or heritable aortic disease.
15.Why is surveillance needed after aortic dissection repair?
Repair of the proximal aorta may leave residual dissection and vulnerable downstream segments. Surveillance detects enlargement, persistent false-lumen problems and later complications requiring treatment. For repaired acute dissection with residual aortic disease, the 2022 ACC/AHA guidance recommends CT or MRI at one, six and 12 months, then annually if stable. The schedule differs from some uncomplicated aneurysm-repair pathways, so the presence of residual disease is a critical qualifier when choosing follow-up.
Apply it
After type A repair, postoperative imaging still shows a dissected descending thoracic aorta. Establish serial cross-sectional surveillance rather than following only the repaired root with echocardiography and assuming the remaining aorta is protected.
Common pitfall: Equating successful proximal repair with cure of the entire aorta can miss progressive distal enlargement; surveillance must cover the remaining diseased segments.
16.How does bicuspid valve disease change aortic assessment?
Bicuspid valve disease requires assessment of both valve function and the aortic root and ascending aorta. The 2022 ACC/AHA guidance recommends aortic replacement at 5.5 cm, with lower thresholds reasonable in selected patients with additional risk factors or when valve surgery is already indicated. Concomitant replacement can be reasonable at 4.5 cm during surgical valve replacement. First-degree relatives should undergo screening for bicuspid valve and aortic dilation because valve morphology can signal a familial aortopathy.
Apply it
A patient needs surgical replacement of a severely stenotic bicuspid valve and has a 4.7-cm ascending aorta. Consider the concomitant aortic-replacement threshold rather than waiting automatically for the isolated-aneurysm threshold to be reached.
Common pitfall: Evaluating only the valve gradient misses associated aortopathy, while applying the 4.5-cm concomitant threshold to every isolated bicuspid aneurysm removes an essential clinical qualifier.
17.Why does a periannular abscess change endocarditis management?
A periannular abscess indicates extension of infection beyond the valve leaflet into surrounding tissue. It can cause fistula formation, prosthetic dehiscence and conduction-system injury, making antibiotics alone insufficient for many patients. New atrioventricular conduction abnormalities are an important clue to invasive aortic valve infection. Transesophageal echocardiography and complementary imaging help define extension. The operative concern is uncontrolled local infection and structural destruction, rather than simply the presence of a positive blood culture.
Apply it
A patient with a prosthetic aortic valve has persistent bacteremia and a new conduction delay. Investigate periannular extension promptly and obtain surgical assessment when imaging identifies an abscess rather than waiting for antibiotics to finish.
Common pitfall: Interpreting a new conduction defect as an incidental medication effect can obscure invasive infection near the aortic annulus and delay necessary source control.
JCS 2026 Guideline on the Management of Infective Endocarditis
18.How does hemodynamic status determine operative timing in endocarditis-related valve failure?
Infective endocarditis can cause acute severe regurgitation through leaflet destruction, perforation or prosthetic disruption. Valve failure causing pulmonary edema or cardiogenic shock warrants emergency surgery, generally within 24 hours, alongside stabilization and antimicrobial treatment. Antibiotics cannot restore destroyed valve mechanics, and completion of the antimicrobial course is not a prerequisite. In contrast, stable patients who meet other surgical indications can undergo urgent surgery within several days. The [JCS 2026 guideline](https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-25-0987/_html/-char/en) distinguishes these emergency and urgent pathways.
Apply it
A patient receiving appropriate antibiotics for aortic endocarditis develops acute severe regurgitation, pulmonary edema and worsening perfusion. Stabilize ventilation and circulation while arranging emergency valve surgery, generally within 24 hours. A stable patient with an operative indication from locally uncontrolled infection follows an urgent pathway within several days rather than waiting for antibiotic completion.
Common pitfall: Calling all endocarditis operations 'urgent' obscures a treatment-critical distinction: pulmonary edema or cardiogenic shock from valve failure requires emergency surgery. Improving fever does not establish that destructive valve dysfunction can safely wait.
JCS 2026 Guideline on the Management of Infective Endocarditis
Cardiac — Congenital Heart Disease5–10%
19.How do tetralogy anatomy, repair and late complications connect?
Tetralogy of Fallot comprises a ventricular septal defect, right ventricular outflow obstruction, an overriding aorta and right ventricular hypertrophy. Outflow obstruction limits pulmonary flow and promotes right-to-left shunting across the ventricular defect toward the aorta. Complete repair closes the defect and relieves outflow obstruction. Residual obstruction, pulmonary regurgitation and arrhythmias can remain or develop later. Chronic pulmonary regurgitation volume-loads and enlarges the right ventricle, so successful childhood correction of cyanosis does not eliminate lifelong surveillance or possible later pulmonary valve replacement.
Apply it
An adult with repaired tetralogy develops reduced exercise capacity and palpitations. Assess pulmonary regurgitation, right ventricular size and function, residual obstruction and rhythm rather than assuming the childhood operation permanently normalized physiology.
Common pitfall: A large ventricular septal defect does not determine shunt direction alone; outflow resistance explains cyanosis, while postoperative valve competence helps determine late right ventricular loading.
20.How do atrial and ventricular left-to-right shunts load different chambers?
A large ASD directs left atrial blood into the right heart, volume-loading the right ventricle. A large VSD without pulmonary outflow obstruction can produce pulmonary overcirculation and increased pulmonary venous return, volume-loading the left ventricle. Defect size and pulmonary vascular resistance influence shunt magnitude. Thus, a septal communication must be interpreted with chamber enlargement and pulmonary-flow physiology. [AATS congenital physiology](https://www.aats.org/tsra-primer-approach-to-congenital-defects).
Apply it
An infant with a large VSD develops tachypnea, pulmonary edema and poor growth. Connect the findings to pulmonary overcirculation rather than applying the cyanotic physiology of tetralogy.
Common pitfall: Calling every septal defect physiologically equivalent misses right ventricular volume loading from an ASD versus increased pulmonary venous and left ventricular loading from a substantial VSD.
Approach to… | The American Association for Thoracic Surgery | AATS
21.Which findings distinguish coarctation from an isolated intracardiac shunt?
Coarctation narrows the aorta, commonly near the ductal insertion, creating proximal pressure loading and reduced distal perfusion. Older patients can have higher arm than leg pressures, diminished lower-extremity pulses and exertional leg symptoms. Severe neonatal obstruction can cause low output as ductal support disappears. Assess four-extremity pressures and pulses alongside aortic imaging. [AATS congenital obstruction](https://www.aats.org/tsra-primer-approach-to-congenital-defects).
Apply it
A young adult has hypertension, weak femoral pulses and leg fatigue. The upper-to-lower pressure and pulse discrepancy directs evaluation toward aortic obstruction.
Common pitfall: Measuring only arm blood pressure can identify hypertension while missing the anatomical obstruction and impaired lower-body perfusion that explain it.
Approach to… | The American Association for Thoracic Surgery | AATS
22.How does single-ventricle physiology determine stabilization and staged palliation?
In hypoplastic left heart syndrome, systemic flow depends on the ductus; closure can cause circulatory collapse, and prostaglandin E maintains patency during stabilization. Stage I palliation establishes systemic output, an adequate pulmonary-flow source and unobstructed mixing. A bidirectional Glenn routes superior caval return directly to the pulmonary arteries; Fontan completion adds inferior caval return. Because pulmonary flow then lacks a subpulmonary ventricular pump, low pulmonary vascular resistance, unobstructed pulmonary pathways and adequate ventricular function are essential. [AATS single-ventricle pathway](https://www.aats.org/tsra-primer-the-single-ventricle-pathway).
Apply it
A neonate with hypoplastic left heart syndrome deteriorates as the ductus closes. Restore ductal support while planning palliation rather than treating the resulting shock as an isolated myocardial problem.
Common pitfall: A higher systemic oxygen saturation does not alone prove improved systemic delivery in parallel circulation; excessive pulmonary flow can divert output from the systemic circulation.
The Single… | The American Association for Thoracic Surgery | AATS
Cardiac — General Management10–20%
23.How do decompression, cardioplegia and systemic delivery protect the patient during bypass?
Cardioplegia reduces myocardial energy demand through controlled arrest, but protection requires effective distribution and redosing. Aortic regurgitation can impair antegrade delivery and fill the left ventricle. Bronchial return can also cause filling despite adequate venous drainage; venting prevents distension, elevated wall tension and increased oxygen demand. Separately, systemic oxygen delivery depends on pump flow and arterial oxygen content, including hemoglobin. High arterial saturation therefore does not exclude low delivery from inadequate flow or marked hemodilution.
Apply it
An arrested ventricle enlarges despite satisfactory systemic flow. Assess vent function and regurgitant filling. If venous saturation falls or lactate rises, also assess flow and oxygen-carrying capacity rather than relying on oxygenator saturation.
Common pitfall: Adequate circuit flow does not establish adequate ventricular decompression or cardioplegia distribution, and a recorded cardioplegia volume does not establish successful myocardial protection.
24.How should temporary pacing be selected after postoperative complete heart block?
Temporary pacing supplies a perfusing rhythm while conduction recovers or permanent pacing is assessed. With complete AV block and usable atrial activity, dual-chamber pacing can coordinate atrial and ventricular stimulation; VVI pacing is commonly used when atrial fibrillation prevents useful atrial tracking. Atrial-only pacing cannot overcome absent AV conduction. Confirm capture by a myocardial response after the pacing stimulus, and assess sensing separately from output. [AATS temporary pacemakers](https://www.aats.org/tsra-primer-temporary-pacemakers).
Apply it
After valve surgery, P waves continue but ventricular conduction fails and blood pressure falls. Establish effective ventricular pacing rather than increasing an atrial-only pacing rate.
Common pitfall: Visible pacing spikes show generator output, not successful myocardial capture; verify the subsequent electrical response and effective perfusion.
Temporary… | The American Association for Thoracic Surgery | AATS
25.Which donor-heart findings matter before transplantation procurement?
Donor assessment integrates history, hemodynamics, ventricular function, structural disease, coronary risk and donor–recipient size matching. A modest troponin rise after resuscitation must be interpreted with timing and imaging rather than used alone to reject an organ. Before procurement, verify donation authorization, blood group and relevant donor documentation. Coordinate cross-clamping and transport with the recipient team to limit ischemic time, and ensure cardioplegic arrest and ventricular decompression during preservation. [AATS heart transplantation](https://www.aats.org/tsra-primer-heart-transplantation).
Apply it
A donor underwent CPR and has mildly elevated troponin but satisfactory ventricular function. Integrate the arrest history, hemodynamics and imaging rather than treating the biomarker as an isolated verdict.
Common pitfall: A technically successful procurement cannot compensate for an unrecognized compatibility problem, unsuitable graft function or avoidable preservation delay.
Heart… | The American Association for Thoracic Surgery | AATS
26.How does the 4Ts score guide suspected HIT evaluation?
The 4Ts score evaluates thrombocytopenia magnitude, timing, thrombosis and alternative causes. Scores of 0–3 indicate low probability, 4–5 intermediate probability and 6–8 high probability. Low probability generally argues against HIT testing or empiric treatment; intermediate or high probability warrants heparin cessation, laboratory evaluation and probability- and bleeding-risk-appropriate nonheparin anticoagulation. Typical onset is days 5–10. A fall within one day can support rapid-onset HIT after heparin exposure within the preceding 30 days, so recent exposure history is essential.
Apply it
A platelet count falls immediately after bypass, then begins recovering, without thrombosis or heparin exposure during the preceding 100 days. This timing and the bypass-related alternative favor a low score. An immediate fall after heparin re-exposure 14 days earlier would receive a different timing assessment.
Common pitfall: An immediate postoperative fall is not automatically HIT, but neither can it be dismissed without checking recent heparin exposure and calculating the full score.
ASH Pocket Guide: Diagnosis and Management of Heparin-Induced Thrombocytopenia
27.Why do HIT immunoassays and functional assays answer different questions?
HIT immunoassays detect antibodies against platelet factor 4–heparin complexes, but antibody detection alone does not prove clinically important platelet activation. Functional assays assess whether the antibodies activate platelets under test conditions. Interpretation combines clinical probability, immunoassay characteristics and functional results. A strongly positive immunoassay in a high-probability patient has different implications from a weak positive in a low-probability patient. The testing sequence is therefore a clinical reasoning process rather than a binary response to any detectable antibody.
Apply it
A patient has a compatible delayed platelet fall and thrombosis, followed by a positive HIT immunoassay. Arrange functional confirmation when appropriate while managing the substantial clinical probability instead of treating the assay result in isolation.
Common pitfall: Calling every positive immunoassay definitive HIT confuses antibody presence with pathogenic platelet activation and can lead to an inaccurate lifelong heparin allergy label.
ASH Pocket Guide: Diagnosis and Management of Heparin-Induced Thrombocytopenia
28.What treatment is required when acute HIT is strongly suspected?
Acute HIT is a prothrombotic immune disorder, not simply a low-platelet bleeding syndrome. With high clinical probability, stop heparin and initiate an appropriate nonheparin anticoagulant while testing proceeds, unless a specific contraindication changes management. Heparin flushes and other hidden exposures must also be addressed. Choice of alternative depends on stability, bleeding risk, organ function and procedural needs. Early warfarin initiation before platelet recovery is inappropriate because it can worsen the prothrombotic imbalance.
Apply it
A patient develops a major platelet fall several days after heparin exposure and a new venous thrombosis. Stop all heparin sources and begin suitable nonheparin anticoagulation rather than withholding anticoagulation because the platelet count is low.
Common pitfall: Stopping heparin without providing alternative anticoagulation leaves the patient exposed to HIT-associated thrombosis; substituting low-molecular-weight heparin does not solve the immune mechanism.
ASH Pocket Guide: Diagnosis and Management of Heparin-Induced Thrombocytopenia
29.How do restrictive transfusion and targeted hemostasis fit together?
The 2021 patient blood management guideline recommends a restrictive rather than liberal red-cell strategy in cardiac surgery, reducing exposure without increased mortality or morbidity in studied settings. Active hemorrhage, perfusion and ischemia still govern immediate care. For postoperative bleeding, assess residual anticoagulation, platelet dysfunction and fibrinogen-related defects using a treatment algorithm, including viscoelastic testing where available. Correct demonstrated abnormalities, but urgently assess a surgical source when substantial bleeding persists despite adequate correction.
Apply it
Stable postoperative anemia can follow a restrictive strategy. Brisk drainage with worsening hemodynamics requires simultaneous resuscitation, hemostatic assessment and source-control evaluation rather than automatic application of a stable-patient hemoglobin rule.
Common pitfall: Normalizing every hemoglobin causes unnecessary exposure, while repeatedly giving empiric products after coagulation correction can delay control of a focal surgical bleed.
30.When can CABG improve survival in ischemic cardiomyopathy?
The 2021 ACC/AHA/SCAI coronary revascularization guideline recommends CABG to improve survival in patients with stable ischemic heart disease, multivessel coronary disease, LVEF <35%, and anatomy appropriate for CABG (Class I). For selected patients with multivessel disease and LVEF 35–50%, CABG is reasonable to improve survival (Class IIa). These recommendations distinguish severe from less severe ventricular dysfunction; they do not make low LVEF alone a contraindication to surgery. Selection requires suitable coronary anatomy and assessment of operative risk and comorbidity alongside heart-failure medical therapy. Primary recommendation table: https://www.heart.org/-/media/PHD-Files-2/Science-News/2/2021/2021-Coronary-Artery-Revascularization-Guideline-Slide-Set.pdf
Apply it
A patient with stable ischemic heart disease, LVEF 30%, graftable multivessel coronary disease, and acceptable surgical risk fits the 2021 Class I survival recommendation. Recommend CABG alongside guideline-directed medical therapy rather than excluding surgery solely because ventricular function is severely reduced.
Common pitfall: Do not replace the 2021 Class I boundary of LVEF <35% with ≤35%. An LVEF of exactly 35% falls within that guideline's 35–50% Class IIa category. Also, reduced LVEF without relevant multivessel coronary disease does not establish this CABG survival indication.
ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
General Thoracic — Lung20–30%
31.How is predicted postoperative function estimated for lobectomy?
For a segment-count estimate, predicted postoperative function equals preoperative function multiplied by the fraction of functioning lung segments remaining. A conventional calculation uses 19 total segments when all are functioning and contribute equally. The same framework can estimate postoperative FEV1 or DLCO. Obstructed, destroyed or disproportionately functioning segments violate the equal-contribution assumption. State whether values are absolute or percent predicted, and identify the planned resection; otherwise, an apparently precise calculation can conceal an incorrect denominator or physiological assumption.
Apply it
A patient has preoperative FEV1 of 80% predicted and will lose five equally functioning segments from a total of 19. Estimate postoperative FEV1 as 80 × 14/19, approximately 59% predicted, before integrating other risk measures.
Common pitfall: Subtracting the percentage of segments removed directly from percent-predicted FEV1 is incorrect; multiply baseline function by the remaining functional fraction and state the assumptions.
ers_ests_clinical_guidelines.pdf · AATS TSRA Primer: Thoracic Imaging Studies
32.Why is differential perfusion useful before pneumonectomy?
Pneumonectomy removes an entire lung, whose functional contribution may differ substantially from its anatomical size. Differential perfusion helps estimate how much function will be lost. Predicted postoperative function can be calculated as baseline function multiplied by one minus the perfusion fraction supplied to the lung being removed. This is particularly useful when tumor obstruction or vascular disease reduces that lung's contribution. The estimate still requires broader assessment of gas transfer, exercise capacity and the patient's overall condition.
Apply it
Preoperative FEV1 is 2.0 L, and the lung planned for removal receives 30% of total perfusion. Estimated postoperative FEV1 is 2.0 × 0.70, or 1.4 L, assuming perfusion reasonably represents functional contribution.
Common pitfall: Assuming pneumonectomy always removes half of total lung function ignores asymmetric perfusion and may substantially overestimate or underestimate the functional cost of the operation.
AATS TSRA Primer: Thoracic Imaging Studies · ers_ests_clinical_guidelines.pdf
33.Why should FEV1 and DLCO both be assessed before lung resection?
FEV1 describes expiratory airflow, whereas DLCO assesses gas-transfer capacity across the alveolar-capillary system. Either can be impaired independently, so acceptable spirometry does not exclude substantial physiological risk. Predicted postoperative values estimate the reserve remaining after the intended resection. Discordant results should prompt investigation and, when appropriate, exercise assessment. The useful distinction is between moving air and transferring oxygen; a patient may preserve one function while having important limitations in the other.
Apply it
A candidate for lobectomy has relatively preserved FEV1 but markedly reduced DLCO. Do not classify the patient as low risk from spirometry alone; calculate postoperative gas-transfer reserve and assess exercise performance as indicated.
Common pitfall: Using a satisfactory FEV1 as a complete pulmonary clearance ignores diffusion impairment, pulmonary vascular disease or other causes of limited gas-exchange reserve after resection.
34.How should lung-function and exercise thresholds guide integrated operative-risk assessment?
The AATS chapter presents one assessment framework: both ppoFEV1 and ppoDLCO above 60% predicted are reassuring; values of 30–60% prompt further functional assessment, and values below 30% indicate high risk. Its screening thresholds include stair climbing above 22 m or shuttle walking above 400 m, with CPET for poor performance. Its peak oxygen-consumption bands are above 15, 10–15 and below 10 mL/kg/min; the chapter's description of the lowest band as generally prohibitive is framework-specific. The [2025 ERS/ESTS guideline](https://publications.ersnet.org/content/erj/66/5/2500156) instead categorizes predicted postoperative FEV1 and DLCO as at least 60% predicted, 40–59% and below 40%, corresponding to normal, moderate and high risk. Peak oxygen consumption below 12 mL/kg/min signals increased risk. These thresholds are not interchangeable, and increased risk does not automatically exclude treatment.
Apply it
A patient has ppoFEV1 59% and ppoDLCO 56%, climbs only 12 m and achieves peak oxygen consumption of 12 mL/kg/min. The predicted postoperative values fall in the 2025 moderate-risk category, and the exercise findings warrant integrated assessment. A peak value of exactly 12 does not satisfy the newer below-12 threshold, but it does not erase the other risk findings. Compare resection extent and approach, cardiac status, comorbidity, oncological benefit, alternatives and patient preferences.
Common pitfall: Combining the AATS 30% boundary with the 2025 12 mL/kg/min threshold creates an unsupported hybrid algorithm. Neither a single postoperative estimate nor a low exercise value should become an automatic operability verdict without the full clinical assessment.
AATS TSRA Primer: Thoracic Imaging Studies · ers_ests_clinical_guidelines.pdf
35.Why do suspicious mediastinal nodes require tissue assessment?
Mediastinal nodal involvement can change the treatment strategy for non-small cell lung cancer. Enlarged or FDG-avid nodes are suspicious, but imaging cannot reliably distinguish metastasis from inflammatory or infectious uptake. Tissue assessment is therefore important when nodal status will determine management. Conversely, a small or minimally avid node is not automatically benign in every clinical setting. The decisive principle is to establish clinically consequential nodal disease rather than assigning definitive cancer involvement from imaging appearance alone.
Apply it
A potentially resectable lung tumor is accompanied by an FDG-avid mediastinal node in a patient with prior granulomatous disease. Obtain nodal tissue before excluding surgery or assigning treatment based solely on the PET finding.
Common pitfall: Calling every PET-positive node metastatic can deny potentially useful treatment, while calling every nonenlarged node benign overlooks the possibility of occult nodal involvement.
36.How do nodal anatomy and systematic sampling determine staging adequacy?
EBUS accesses mediastinal stations 2, 4 and 7 and also hilar or intrapulmonary nodes. EUS complements access to stations 8 and 9 and overlaps at selected left paratracheal and subcarinal stations. Stations 5 and 6 generally require surgical access, such as VATS. Systematic staging examines the mediastinum beyond the single imaging target; the 2015 joint guideline specifically describes assessment and sampling of 4R, 4L and 7 in an abnormal mediastinum. Adequacy requires relevant station coverage and representative tissue. The [2026 ERS/ESGE/ESTS guideline abstract](https://pubmed.ncbi.nlm.nih.gov/42167778/) supports the current emphasis on systematic endosonography; the 2015 document supplies the anatomical details.
Apply it
A left upper-lobe tumor has a suspicious station 5 node. Negative EBUS samples from 4L and 7 do not answer the station 5 question; arrange access that can safely sample that target while completing appropriate staging.
Common pitfall: A technically successful targeted biopsy is not necessarily systematic staging, and an anatomically inaccessible node is not cleared by negative samples elsewhere.
37.What distinguishes an inadequate sample from adequately negative systematic mediastinal staging?
A specimen without representative nodal material is nondiagnostic; absence of malignant cells alone cannot establish a negative node. Adequately negative systematic endosonography requires appropriate nodal coverage and satisfactory samples, including assessment of consequential imaging abnormalities. The [2026 ERS/ESGE/ESTS guideline abstract](https://pubmed.ncbi.nlm.nih.gov/42167778/) states the recommendation against routine add-on confirmatory mediastinoscopy after negative systematic endosonography. This differs from the historical 2015 guideline, which recommended subsequent surgical staging after negative endosonography in patients with abnormal mediastinal or hilar nodes on imaging.
Apply it
If systematic staging adequately samples the relevant stations and is negative, routine confirmatory mediastinoscopy is not recommended by the 2026 guideline. If a suspicious node yields scant material without representative lymphoid tissue, obtain adequate tissue through repeat targeted endosonography or an anatomically appropriate surgical approach. An inaccessible consequential station may require a different sampling route.
Common pitfall: The recommendation against routine mediastinoscopy applies to negative systematic staging, not to unresolved sampling failure. A report stating only 'no malignant cells' does not demonstrate adequacy. The 2015 document supports the historical comparison; its recommendation should not be presented as the basis for the newer practice.
38.What oncological principles must minimally invasive lung resection preserve?
A minimally invasive approach changes access, not the need for complete tumor removal and appropriate nodal assessment. The operation must provide an oncologically suitable resection, adequate margins and safe management of hilar structures. Conversion to an open approach is appropriate when exposure, bleeding control or tumor clearance requires it. The meaningful comparison is the quality and safety of the completed cancer operation, rather than whether the entire procedure can be finished through the initially chosen incisions.
Apply it
During VATS lobectomy, dense hilar involvement prevents safe vascular dissection and threatens complete resection. Change the operative approach when needed to achieve safe control and oncological goals rather than persisting solely to preserve minimally invasive access.
Common pitfall: Treating conversion as failure can encourage unsafe dissection or compromise margins; the access strategy must remain subordinate to complete and technically sound cancer surgery.
AATS TSRA Primer: VATS Lung Surgery · NCI Non-Small Cell Lung Cancer Treatment PDQ
39.Which postoperative findings suggest lobar torsion?
Lobar torsion occurs when a remaining lobe rotates around its bronchovascular pedicle, compromising venous drainage, arterial inflow and the bronchus. Rapid unexplained lobar opacity after resection, hypoxemia, fever or clinical deterioration should raise suspicion, especially when the lobe appears abnormally positioned or perfused. It can resemble atelectasis or pneumonia, but vascular compromise makes delay dangerous. CT and bronchoscopy can help identify distorted anatomy; the key cue is abrupt postoperative deterioration with a potentially ischemic remaining lobe.
Apply it
After right upper lobectomy, a patient develops hypoxemia and rapidly increasing middle-lobe opacity despite pulmonary toilet. Investigate torsion with urgent anatomical assessment instead of assuming retained secretions explain the entire postoperative change.
Common pitfall: Repeated treatment for ordinary atelectasis can delay recognition of torsion; a rotated bronchovascular pedicle creates ischemia that bronchodilators or secretion clearance cannot reverse.
40.Why does suspected lobar torsion require urgent operative assessment?
A twisted bronchovascular pedicle can rapidly render a lobe nonviable and can create dangerous thrombotic and infectious consequences. Suspected torsion therefore requires urgent surgical assessment rather than prolonged empiric treatment for pneumonia. Operative management depends on viability and may require resection. Manipulation or detorsion of a severely compromised lobe must be planned carefully because of thrombus and reperfusion concerns. The decision is driven by vascular compromise, not simply the degree of radiographic collapse or the amount of supplemental oxygen required.
Apply it
CT demonstrates an abnormally rotated, poorly enhancing remaining lobe after lobectomy. Arrange urgent operative assessment and determine viability rather than scheduling interval imaging after a trial of antibiotics or repeated bronchoscopic secretion clearance.
Common pitfall: Assuming that reopening the bronchus alone cures torsion ignores the associated vascular obstruction and the possibility that the affected lobe is already infarcted.
41.How can cardiac herniation present after pneumonectomy?
After intrapericardial pneumonectomy, the heart can herniate through a pericardial defect and twist or obstruct major vascular connections. Sudden hypotension, arrhythmia or collapse, sometimes associated with repositioning, should trigger concern for this mechanical emergency. Chest imaging may show abnormal cardiac displacement, but an unstable patient requires immediate surgical attention. The discriminating context is recent pneumonectomy with a pericardial opening; labeling the event as routine postoperative atrial arrhythmia or hypovolemia can miss a rapidly fatal structural problem.
Apply it
A patient collapses after turning in bed following intrapericardial pneumonectomy. Consider cardiac herniation alongside other causes of shock and obtain immediate operative assessment when the history and imaging suggest displacement through the pericardial defect.
Common pitfall: Treating the associated arrhythmia alone can miss the mechanical cause of collapse; correcting rhythm does not untwist obstructed cardiac inflow or outflow.
42.Why is fluid administration cautious after pneumonectomy?
After pneumonectomy, the remaining lung receives the entire pulmonary blood flow and is vulnerable to postoperative lung injury and edema. Excessive fluid administration can worsen respiratory compromise, so volume decisions require careful assessment of perfusion and actual volume responsiveness. Restriction does not mean ignoring hemorrhage or shock. The useful principle is to avoid reflexive large fluid loads while identifying the cause of hypotension and balancing organ perfusion against the limited pulmonary reserve of a single remaining lung.
Apply it
A pneumonectomy patient develops hypotension and increasing oxygen requirements after repeated fluid boluses. Reassess bleeding, cardiac function and volume responsiveness rather than continuing automatic crystalloid loading in a patient whose remaining lung may be becoming edematous.
Common pitfall: Applying liberal fluid replacement without reassessment can worsen remaining-lung injury; an equally rigid refusal to resuscitate genuine shock also misapplies cautious fluid management.
General Thoracic — Trachea/Bronchi3–10%
43.When should a persistent air leak suggest major airway injury?
Following thoracic trauma, a large persistent air leak, failure of lung re-expansion despite a functioning chest drain, pneumomediastinum or substantial subcutaneous emphysema can indicate tracheobronchial disruption. Bronchoscopy directly assesses airway anatomy and helps define the location and extent of injury. A chest drain treats pleural air but does not repair a disrupted central airway. The combination of persistent leakage and failed re-expansion is more concerning than an uncomplicated pneumothorax that resolves after effective drainage.
Apply it
After blunt chest trauma, a correctly positioned chest tube has continuous large-volume bubbling and the lung remains collapsed. Arrange bronchoscopic evaluation for major airway injury rather than repeatedly replacing an otherwise functioning drain.
Common pitfall: Attributing every persistent pneumothorax to chest-tube malfunction delays recognition of a central airway disruption that requires anatomical diagnosis and potentially operative repair.
44.How does bronchoscopy help during major airway bleeding?
Major airway bleeding threatens life through airway obstruction and contamination of the unaffected lung as well as blood loss. Bronchoscopy can clear obstructing blood, identify the bleeding side and guide isolation or other control measures. Airway stabilization must accompany investigation; diagnostic imaging should not delay protection when oxygenation is failing. The central distinction is that airway patency and preservation of ventilated lung can be more immediately consequential than an imprecise estimate of expectorated blood volume.
Apply it
A patient with ongoing airway hemorrhage becomes hypoxemic and cannot clear blood. Secure effective ventilation and use bronchoscopy to clear and localize bleeding while preparing definitive control, instead of sending an unstable patient for imaging first.
Common pitfall: Prioritizing diagnostic certainty before securing a threatened airway can allow blood to obstruct ventilation or flood the unaffected lung while the bleeding source remains uncontrolled.
45.Why is the bleeding lung placed dependent?
When the side of major pulmonary bleeding is known, placing that side down can reduce gravity-driven spill of blood into the unaffected lung. This positioning supports protection of the better-functioning lung while airway control and definitive treatment are organized. Bronchoscopically guided isolation may be needed when bleeding continues. Positioning is an interim physiological measure, not source control, and it should be coordinated with ventilation and procedural access rather than treated as sufficient therapy for ongoing life-threatening hemorrhage.
Apply it
Bronchoscopy identifies substantial right-sided bleeding while the left lung remains clear. Place the right side dependent when feasible and coordinate targeted isolation to preserve left-lung ventilation while definitive bleeding control is arranged.
Common pitfall: Placing the unaffected lung down may encourage blood to enter it; protective positioning aims to contain contamination, not simply maximize the usual ventilation-perfusion advantage.
46.When can sleeve resection preserve lung in a central tumor?
A central lung tumor involving a lobar bronchus may sometimes be removed by sleeve lobectomy with bronchial reconstruction, preserving uninvolved lung that a pneumonectomy would sacrifice. Suitability requires complete tumor clearance and a technically sound reconstruction with adequate perfusion and manageable tension. This is an oncological and anatomical decision, not a reason to accept a positive airway margin. Bronchoscopic assessment and careful evaluation of vascular and nodal involvement help determine whether parenchymal preservation is feasible.
Apply it
A centrally located upper-lobe tumor involves the lobar bronchial origin but appears amenable to complete sleeve resection. Compare a reconstructive lobectomy with pneumonectomy while confirming that negative margins and a safe airway anastomosis are achievable.
Common pitfall: Preserving parenchyma at the expense of a positive bronchial margin defeats the oncological purpose; sleeve reconstruction is appropriate only when complete and safe resection is feasible.
General Thoracic — Pleura5–10%
47.When does pleural infection require tube drainage?
Frank pleural pus establishes empyema and requires drainage. In a nonpurulent parapneumonic effusion, pleural fluid pH helps identify a complicated infection: pH at or below 7.2 supports intercostal drainage when fluid is safely accessible. Intermediate pH results require integration with LDH, glucose, imaging and clinical features. Antibiotics treat infection but do not reliably evacuate a loculated infected collection. Correct sample handling matters because local anesthetic contamination and other preanalytical problems can distort pH interpretation.
Apply it
A patient with pneumonia has a safely accessible pleural collection with nonpurulent fluid and pH 7.08. Provide antibiotics and pleural drainage rather than withholding drainage because the aspirate does not visibly resemble pus.
Common pitfall: Requiring frank pus before drainage misses complicated nonpurulent infection; conversely, interpreting a contaminated pH sample without context can lead to an incorrect procedural decision.
2023 BTS Pleural Disease Guideline and Pleural Procedures Statement
48.How should persistent sepsis after pleural drainage be reassessed?
Persistent fever or inflammatory deterioration after chest-tube placement should prompt assessment of drain position, patency and residual collections. Loculations can prevent a single drain from evacuating the infected space. Imaging helps distinguish inadequate drainage from other sources of ongoing illness. Treatment escalation can include additional drainage, intrapleural therapy or surgery according to the residual anatomy and clinical response. A tube visible on a radiograph does not establish effective source control; what matters is whether the infected compartments are actually drained.
Apply it
A pleural-infection patient remains septic with minimal drain output, and ultrasound shows a separate residual locule. Check catheter function and plan further source control rather than assuming the low output means the infection has resolved.
Common pitfall: Escalating antibiotics alone while a large infected locule remains undrained overlooks a mechanical source-control failure that antimicrobial changes cannot reliably correct.
2023 BTS Pleural Disease Guideline and Pleural Procedures Statement
49.Why are intrapleural tPA and DNase used together?
In selected pleural infections with a residual collection after initial chest-tube drainage has ceased, combined tissue plasminogen activator and DNase can improve drainage. The fibrinolytic component disrupts fibrinous septations, while DNase reduces the contribution of extracellular DNA to fluid viscosity. The BTS guideline supports the combination rather than either agent alone. Bleeding risk and suitability require assessment. This strategy supplements appropriate antibiotics and a functioning drain; it does not excuse failure to identify an inaccessible or inadequately drained compartment.
Apply it
Despite antibiotics and a patent drain, a patient has a substantial residual loculated infected collection. Consider combined intrapleural tPA and DNase after assessing bleeding risk and whether the collection communicates with the drain.
Common pitfall: Using tPA or DNase alone as an equivalent substitute ignores the evidence for combination treatment; administering either through a nonfunctioning drain also misses the drainage problem.
2023 BTS Pleural Disease Guideline and Pleural Procedures Statement
50.Why does non-expandable lung favor an indwelling pleural catheter?
Pleurodesis depends on adequate apposition of visceral and parietal pleura. When malignant pleural disease prevents lung expansion after fluid removal, that apposition may be absent and pleurodesis is less likely to succeed. An indwelling pleural catheter can provide repeated symptom-relieving drainage without requiring full expansion. The extent of non-expansion, response to drainage, patient preference and home-management feasibility matter. The key physiological discriminator is whether the lung can re-expand, not merely how often the effusion recurs.
Apply it
A recurrent malignant effusion causes breathlessness that improves after drainage, but imaging repeatedly shows substantial persistent non-expansion. Discuss an indwelling pleural catheter as a practical symptom-control option rather than assuming talc pleurodesis will be effective.
Common pitfall: Choosing pleurodesis solely because the effusion is recurrent ignores its need for pleural apposition; a substantially non-expandable lung creates a different treatment problem.
2023 BTS Pleural Disease Guideline and Pleural Procedures Statement
General Thoracic — Mediastinum5–10%
51.How do thymoma-associated weakness and resectability affect operative planning?
Thymoma is associated with myasthenia gravis. Fluctuating ptosis, diplopia, chewing fatigue, dysphagia or respiratory weakness require assessment before elective resection. Tumor treatment depends on invasion and the feasibility of complete removal, not diameter alone. Complete resection is central for resectable disease; locally advanced tumors may require diagnosis-led systemic treatment, radiation and reassessment. Thymic carcinoma has different behavior and must be distinguished histologically when planning treatment.
Apply it
A patient with a thymic-region mass has fatigable swallowing and extensive vascular involvement. Assess neuromuscular risk and establish a multidisciplinary treatment sequence rather than attempting an unplanned incomplete operation.
Common pitfall: Removing a tumor does not guarantee immediate resolution of associated autoimmune disease, and technically possible debulking is not equivalent to a planned complete oncological resection.
52.Which cues distinguish a mediastinal germ-cell tumor from a presumed thymoma?
A young adult, particularly a man, with a midline mediastinal mass warrants evaluation for an extragonadal germ-cell tumor. Assess AFP, beta-hCG and histology, and exclude a gonadal primary by testicular examination and ultrasound. Pure seminoma requires normal AFP; an unexplained elevated AFP argues against that classification. Nonseminomatous tumors generally begin with chemotherapy, with selected residual disease resected afterward. Benign teratoma instead is treated surgically. [NCI germ-cell tumor reference](https://www.cancer.gov/types/extragonadal-germ-cell/hp/extragonadal-treatment-pdq).
Apply it
A young man has a large mediastinal mass and elevated AFP. Establish the germ-cell diagnosis and treatment sequence rather than proceeding directly to thymectomy.
Common pitfall: Anterior location alone does not identify thymoma; lymphoma and germ-cell tumors also occur there, and their treatment can differ substantially.
Extragonadal Germ Cell Tumors Treatment (PDQ®) - NCI · NCI Thymoma and Thymic Carcinoma Treatment PDQ
53.How can benign thymic conditions be distinguished during mediastinal evaluation?
Thymic hyperplasia and thymic cysts can present as mediastinal masses. Chemical-shift MRI helps distinguish hyperplasia or normal thymus from thymic epithelial tumors; contrast CT defines relationships to vessels, pericardium and lung. These studies answer different questions: tissue characterization helps establish the differential, whereas invasion assessment informs resectability. A mass should therefore be characterized before its size or location is used to select an operation.
Apply it
CT leaves uncertainty between thymic enlargement and a solid thymic tumor. Use chemical-shift MRI to refine that distinction before committing to a tumor-directed treatment pathway.
Common pitfall: Calling all thymic-region enlargement malignant ignores benign hyperplasia and cysts; conversely, a smooth contour alone cannot establish benign behavior.
General Thoracic — Esophagus5–10%
54.How do imaging and physiology determine urgent treatment of esophageal perforation?
Contrast-enhanced CT, with CT esophagography when appropriate, identifies the defect and maps mediastinal or pleural contamination. Shock, severe sepsis, uncontained leakage or major contamination require urgent source control. Operative principles include debridement, stopping further leakage and adequate drainage, with repair, diversion or resection chosen according to viability and underlying disease. Antibiotics, withholding oral intake and early nutritional support accompany treatment. Sealing the lumen alone does not evacuate contaminated extraluminal spaces.
Apply it
After forceful vomiting, a patient develops shock and an uncontained thoracic leak with pleural soilage. Resuscitate, give antimicrobials and arrange urgent operative control of both the defect and contaminated spaces.
Common pitfall: A small measured defect can cause extensive contamination; defect length alone does not determine whether observation, endoscopy or surgery is appropriate.
55.Which complete criteria support nonoperative esophageal perforation management?
WSES selection requires stability, presentation within 24 hours, no sepsis, a contained cervical or thoracic disruption with minimal extravasation and drainage back into the esophagus, no massive pleural contamination and no preexisting esophageal disease. Close specialist surveillance and round-the-clock surgical and radiological expertise must be available. Treatment includes withholding oral intake, broad-spectrum antibiotics, nutritional support and drainage when required. Perforation through an obstructing or malignant lesion fails the underlying-disease criterion and may change definitive treatment toward resection or another disease-directed strategy.
Apply it
A contained iatrogenic leak is recognized after six hours in a stable patient with a previously normal esophagus and minimal contamination. Specialist nonoperative treatment can be considered. The same imaging appearance above an obstructing cancer does not satisfy these criteria.
Common pitfall: Early detection and a small contained leak are insufficient when sepsis, preexisting esophageal disease or inadequate surveillance capability is present.
56.How do locoregional and distant assessments guide esophageal cancer treatment?
Esophageal cancer assessment separates local wall invasion and regional nodes from distant spread. EUS evaluates tumor depth and regional nodes, with needle sampling when indicated; CT examines the chest and abdomen, and PET-CT can identify otherwise occult distant metastases. These findings determine whether treatment pursues a curative local or multimodality strategy or a different systemic and symptom-control approach. A technically removable primary is not enough to justify esophagectomy without evaluating disease distribution. [NCI esophageal cancer reference](https://www.cancer.gov/types/esophageal/hp/esophageal-treatment-pdq).
Apply it
A biopsy-confirmed esophageal cancer appears locally resectable. Complete locoregional and distant assessment before selecting an esophagectomy pathway; a consequential distant lesion must be resolved.
Common pitfall: EUS and PET-CT are complementary: detailed wall assessment cannot substitute for assessment of distant spread.
57.Which findings support achalasia, what must be excluded before treatment, and how does the motor subtype guide therapy?
Achalasia involves myenteric plexus degeneration, impaired esophagogastric-junction relaxation and loss of organized esophageal peristalsis. High-resolution manometry establishes the motor pattern and subtype. Upper endoscopy is mandatory before treating presumed primary achalasia to exclude pseudoachalasia and mechanical junctional obstruction. A timed barium esophagram assesses emptying and provides an objective measure for follow-up. Treatment lowers outflow resistance without restoring normal innervation. Pneumatic dilation, Heller myotomy and POEM are effective options for suitable patients with types I and II; spastic type III disease favors a longer myotomy, commonly achievable with POEM. [ASGE achalasia guideline](https://www.asge.org/home/resources/publications/guidelines/asge-guideline-on-the-management-of-achalasia).
Apply it
An older patient develops dysphagia over several months with substantial recent weight loss, and manometry shows impaired junctional relaxation with absent organized peristalsis. Perform upper endoscopy before selecting dilation or myotomy. The age, short symptom history and marked weight loss raise concern for malignant pseudoachalasia. If endoscopy does not explain the obstruction but suspicion persists, further evaluation with cross-sectional imaging and/or endoscopic ultrasound can identify underlying malignancy. Select treatment for primary achalasia only after adequately excluding obstructing pathology.
Common pitfall: Neither elevated resting sphincter pressure nor a bird-beak appearance alone establishes primary achalasia. Endoscopy can appear normal in early achalasia, while an unrevealing mucosal examination does not necessarily exclude an infiltrating malignancy in a patient with concerning clinical features.
General Thoracic — Chest Wall/Diaphragm1–8%
58.Why can a left thoracoabdominal stab wound require laparoscopy?
A penetrating left thoracoabdominal wound can produce a small diaphragmatic injury that is not reliably excluded by CT. In a hemodynamically stable patient without peritonitis, EAST conditionally favors laparoscopy over CT for diagnosing such injuries because direct inspection reduces missed defects. The recommendation is conditional and depends on procedural feasibility and patient circumstances. Missing a small injury matters because abdominal viscera can later herniate through it, creating obstruction or strangulation despite a reassuring initial examination.
Apply it
A stable patient has a left lower-chest stab wound, no peritonitis and a CT without an obvious diaphragmatic defect. Consider diagnostic laparoscopy because a small penetrating injury may remain occult on cross-sectional imaging.
Common pitfall: Using a negative CT as definitive exclusion in this specific penetrating left-sided scenario can miss a small defect with important delayed herniation consequences.
EAST Guideline: Diaphragmatic Injury, Evaluation and Management
59.How do timing, associated injuries and side affect diaphragmatic injury management?
For acute traumatic diaphragmatic repair in stable patients, EAST conditionally favors abdominal access because it permits evaluation and treatment of associated abdominal injuries. Delayed herniation has different adhesions and organ involvement, so the route is individualized. Selected stable patients with penetrating right-sided injury and no peritonitis can undergo nonoperative management; liver protection reduces but does not abolish herniation concerns. Large or concerning defects, associated injuries and other operative indications can favor repair.
Apply it
An acute tear with suspected abdominal injury favors abdominal assessment. A small right-sided penetrating injury without peritonitis may permit selected observation, while the left-sided occult-injury diagnostic recommendation remains different.
Common pitfall: Conditional right-sided observation is not a universal diaphragm rule, and the preferred acute approach does not automatically determine access for delayed herniation.
EAST Guideline: Diaphragmatic Injury, Evaluation and Management
60.What oncological, skeletal and soft-tissue objectives must chest-wall resection and reconstruction accomplish?
Chest-wall tumor resection must achieve tumor-free margins, including involved rib segments and corresponding intercostal tissues when full-thickness resection is required. Reconstruction must provide sufficient chest-wall stability when skeletal support is lost, as well as durable soft-tissue coverage. These are separate functional objectives: a vascularized latissimus dorsi flap supplies coverage but does not necessarily replace missing skeletal support. The AATS operative description identifies PTFE and methyl methacrylate mesh constructs as structural options and describes titanium plates, with or without an accompanying matrix patch. Reconstruction should accommodate the oncologically necessary resection. [AATS resection and coverage](https://www.aats.org/resources/anterior-chest-wall-resection-and-reconstruction-2); [AATS full-thickness reconstruction](https://www.aats.org/resources/anterior-chest-wall-resection-and-reconstruction-3).
Apply it
For an extensive anterior full-thickness defect extending to the lateral sternum after rib resection, the AATS description illustrates anchoring PTFE through sternal punches to secure the reconstruction and provide stability. Another described approach uses titanium plates molded to the rib contour and screwed to the remaining bony ribs, optionally combined with an acellular collagen matrix patch. Plan vascularized soft-tissue coverage separately according to the remaining tissue and wound requirements.
Common pitfall: A well-perfused flap does not by itself demonstrate adequate skeletal stabilization, and stable reconstruction does not establish tumor-free margins. Assess the defect's location, extent and remaining support when selecting reconstruction; a single universal size threshold cannot replace that assessment.
Anterior Chest… | The American Association for Thoracic Surgery | AATS · Anterior Chest… | The American Association for Thoracic Surgery | AATS
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Maintain approximately equal Cardiac and General Thoracic study time, with the largest individual blocks devoted to acquired cardiac disease and lung.
- For each intervention, identify the anatomy, physiology and clinical consequence that change the decision: CABG versus PCI, surgical valve replacement, aortic repair, lung resection or urgent source control.
- Compare congenital shunt and obstructive physiology, and connect pacing, transplantation and ischemic cardiomyopathy decisions to their specific mechanisms.
- Practise postoperative rescue patterns: ventricular distension, HIT-associated thrombosis, lobar torsion, cardiac herniation, persistent pleural sepsis and uncontained esophageal leakage.
- Calculate predicted postoperative lung function with explicit assumptions and units, then apply functional assessment and CPET pathways rather than treating an estimate as a final operability decision.
- Distinguish systematic cancer staging from targeted or inadequate sampling, and compare thymic, germ-cell, esophageal and chest-wall disease pathways.
- Expand beyond this selective guide using the full matrix, including cardiac tumors and trauma, arrhythmia surgery, ethics, broader transplantation and cardiomyopathy management, and additional congenital and thoracic diseases.
A practical preparation plan
1. Map the complete examination scope
Use the official written matrix as your master checklist. Mark the nine domains and their published ranges, then identify which topics this selective guide covers and which require additional study.
2. Build anatomical and physiological decision maps
For each condition, connect the lesion to its physiological effect, confirming test and treatment-changing finding. Examples include ascending involvement in dissection, pulmonary outflow obstruction in tetralogy, ductal dependence and pleural apposition before pleurodesis.
3. Work calculations and thresholds with qualifiers
Practise segment-based and perfusion-based postoperative estimates, functional testing pathways and 4Ts score boundaries. Learn aortic growth criteria alongside disease category, imaging consistency and concomitant-surgery context.
4. Rehearse complications through their decisive cues
Contrast routine recovery with urgent threats. Explain why sudden lobar opacity, postpneumonectomy collapse, a delayed platelet fall with thrombosis or shock after esophageal rupture changes the immediate management pathway.
5. Use drills to expose reasoning gaps
Answer the 20 questions before reviewing explanations. For every error, write the decisive cue and explain why each alternative fails. Use the flashcards later to recall mechanisms and boundaries without relying on answer recognition.
6. Complete full-scope and current-guidance review
Return to uncovered matrix topics and current ABTS candidate guidance. Resolve staging-edition discrepancies, verify appointment-specific logistics and revisit clinical recommendations in their stated guideline context.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABTS Training and Initial Certification
- ABTS Examination Sequence
- ABTS Qualifying (Written) Exam Matrix
- ABTS Primary Certification Part I (Written) Examination
- ACC Key Takeaways From the 2021 Coronary Revascularization Guidelines
- ACC Decision-Making Approach to Treat Young and Low-Risk AS Patients
- ESC Overview of the 2025 ESC/EACTS Valvular Heart Disease Guidelines
- ACC 2020 Heart Valve Disease Guideline: Key Perspectives, Part 3
- ACC 2022 Aortic Disease Guideline: Key Perspectives, Part 2
- ACC/AHA Issue Aortic Disease Guideline
- JCS 2026 Guideline on the Management of Infective Endocarditis
- American Heart Association: Tetralogy of Fallot
- AATS TSRA Primer: Cardiopulmonary Bypass Fundamentals
- ASH Pocket Guide: Diagnosis and Management of Heparin-Induced Thrombocytopenia
- 2021 STS/SCA/AmSECT/SABM Patient Blood Management Guideline
- AATS TSRA Primer: Thoracic Imaging Studies
- NCI Non-Small Cell Lung Cancer Treatment PDQ
- AATS TSRA Primer: VATS Lung Surgery
- AATS TSRA Primer: Pneumonectomy
- 2023 BTS Pleural Disease Guideline and Pleural Procedures Statement
- AATS TSRA Primer: Thoracic Trauma
- NCI Thymoma and Thymic Carcinoma Treatment PDQ
- 2019 WSES Guidelines: Esophageal Emergencies
- EAST Guideline: Diaphragmatic Injury, Evaluation and Management
- ers_ests_clinical_guidelines.pdf
- 1_full.pdf
- Approach to… | The American Association for Thoracic Surgery | AATS
- The Single… | The American Association for Thoracic Surgery | AATS
- Temporary… | The American Association for Thoracic Surgery | AATS
- Heart… | The American Association for Thoracic Surgery | AATS
- Extragonadal Germ Cell Tumors Treatment (PDQ®) - NCI
- Lambert-Eaton myasthenic syndrome: MedlinePlus Medical Encyclopedia
- Esophageal Cancer Treatment (PDQ®) - NCI
- ASGE | ASGE guideline on the management of achalasia
- Anterior Chest… | The American Association for Thoracic Surgery | AATS
- 2020 ACC/AHA Heart Valve Disease Guideline: Key Perspectives, Part 1 - American College of Cardiology
- Anterior Chest… | The American Association for Thoracic Surgery | AATS
- Client Challenge
- asge-guideline-on-the-management-of-achalasia-2020-february-gie.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.